Breaking News

Dipharma Expands Italian R&D Center to Increase Analytical Services

The new space will increase laboratory space dedicated to analytical R&D activities for small molecules by more than 130%.

Dipharma Francis S.r.l., a global contract development and manufacturing organization (CDMO) and manufacturer of new chemical entities (NCE), generic active pharmaceutical ingredients and advanced intermediates, has completed the expansion of its research and development center for small molecules at its headquarters in Baranzate, Italy. The new space, which increases the Italian laboratory space dedicated to analytical R&D activities by over 130%, will strengthen Dipharma’s analytical ca...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters